HCP stock: buy or sell?
October 18th, 2019
HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests primarily in real estate serving the healthcare industry in the United States.
Should I buy HCP stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best time to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, 2 buy setups work for HCP stock now:
|New all-time high||Yes|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is HCP stock a buy?
Financial institutions and banks publish stock ratings everyday.At Stocks2.com, we detected 10 ratings published for HCP stock in the last month. The general sentiment of these ratings is bullish for HCP stock, with 8 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-9-17||Morgan Stanley||n/a||Equal Weight|
|2019-9-10||JPMorgan Chase & Co.||n/a||Neutral|
|2019-6-13||Raymond James||Market Perform||Outperform|
|2019-1-9||BMO Capital Markets||Market Perform||Outperform|
|2019-1-7||Robert W. Baird||Neutral||Outperform|
HCP stock analysis
After reaching all time highs on October 18th, HCP raised 1.05% to $37.39.
HCP raised 1.05% to $37.39 after reaching all time highs on Oct 18th. HCP shows a sign of strength in the short-term after finally breaking out above $36.80 on October 9th and marking a new rising bottom. On October 18th, HCP hit a new all time high, pushing higher than on Thursday tops. Check different trading setups that use ATHs as triggers. On August HCP price bounced up over the SMA of 50 days demonstrating to be a significant support for this stock.
HCP shares peaked new all time highs back again this week, marking to $37.52. Shares closed at $37.39 and soared 2.86% during the week. Early September HCP plummed a bloodcurdling -5.45% in just one week.
Price pattern shows an uptrend with two rising tops and bottoms, and now finally trading above the $36.07 resistance. Late April HCP price bounced up over the SMA of 20 weeks that acted as support stopping new slides.
HCP stock price history
HCP stock went public on May 23rd, 1985 with a price of $0.001. Since then, HCP stock grew a inf%, with an average of inf% per year. If you had invested right after HCP's IPO a $1,000 in HCP stock in 1985, it would worth $inf today.
1: Adjusted price after possible price splits or reverse-splits.
HCP stock historical price chart
HCP stock reached all-time highs on Oct 18th with a price of $37.52.
HCP stock price target is $35.30How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we found 7 price targets for HCP stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-9-17||Morgan Stanley||Raises Target||$32.00||$35.00||9.4%|
|2019-9-10||JPMorgan Chase & Co.||Raises Target||$32.00||$35.00||9.4%|
|2019-8-1||Stifel Nicolaus||Raises Target||$32.00||$34.00||6.3%|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, HCP was in line with the estimates of the experts and reported an EPS of $0.43 per share. Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual sales report draw a slightly good increase of 2.54% to $1,782.01 million dollars. Instead, its profit margin (compared to sales) rocketed to 59.54%, that is $1,061.09 million.
|2013||$2,110 M||-||$895 M42.4%||-|
|2014||$1,529 M||-27.55%||$922 M60.3%||3.07%|
|2015||$1,798 M||17.63%||$-559.24 M-31.1%||-160.64%|
|2016||$1,981 M||10.16%||$628 M31.7%||-212.25%|
|2017||$1,738 M||-12.27%||$414 M23.8%||-34.02%|
|2018||$1,782 M||2.54%||$1,061 M59.5%||156.20%|
Quarterly financial resultsHCP posted $426.62 million in revenues for 2018-Q4, a -3.31% less compared to previous quarter. Reported quarter earnings marked $831.55 million with a profit margin of 194.92%. Profit margin climbed a 172.39% compared to previous quarter when profit margin was 22.52%. When comparing revenues to same quarter last year, HCP sales marked a neutral movement and stayed constant a 0.55%. Looking back to recent quarterly results, HCP posted 3 negative quarters in a row.
|2017-Q2||$459 M||-||$19 M4.2%||-|
|2017-Q3||$429 M||-6.52%||$-8 M-1.8%||-139.71%|
|2017-Q4||$424 M||-1.10%||$-59 M-13.8%||666.64%|
|2018-Q1||$460 M||8.31%||$40 M8.8%||-168.54%|
|2018-Q2||$455 M||-1.08%||$90 M19.8%||123.56%|
|2018-Q3||$441 M||-2.95%||$99 M22.5%||10.48%|
|2018-Q4||$427 M||-3.31%||$832 M194.9%||736.81%|
|2019-Q1||$421 M||-1.34%||$61 M14.6%||-92.61%|
HCP ownershipWhen you are planning to invest in a company, it's worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For HCP, 0.22% of all outstanding shares are owned by its staff.
Bearish positions for HCP stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to HCP:
|Market cap||$18.4 B||$4.5 B||$252.2 M||$27.1 B||$37.3 B|
|Total shares||491.1 M||189.5 M||34.6 M||372.6 M||405.3 M|
|Float shares||489.8 M||187.3 M||22.4 M||371.3 M||404.4 M|
|- Institutional holdings (%)||97.0%||99.7%||42.8%||91.1%||86.6%|
|- Insider holdings (%)||0.2%||1.3%||32.4%||0.4%||0.2%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Friday, October 18th, 2019|
|Day range||$36.90 - $37.52|
|Average true range||$0.53|
|50d mov avg||$35.22|
|100d mov avg||$33.58|
|200d mov avg||$31.71|
HCP performanceTo measure stock performance is always good to benchmark with competitors or related stocks. We chose Sabra Health Care, Tiptree, Ventas and Welltower as the bechmarking frame for HCP stock.
|SBRASabra Health Care||20.81%||28.98%||18.39%|